ReviewIBRO neuroscience reports2021

The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis.

Mohammad Z I Asha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.